As tests and screenings for chronic conditions improve, Connecticut residents will have better access after lawmakers passed legislation mandating health insurance plans cover biomarker tests starting ...

Biomarker testing is critical for determining optimal therapy early in the non–small lung cancer (NSCLC) treatment process, but research shows uneven insurance coverage of these tests and inconsistent ...

The National Council of Insurance Legislators moved closer to adopting a model law Friday after a robust debate on a biomarker testing coverage regulation. Members are expected to vote in July on the ...

The office of New York Attorney General Eric Schneiderman reached a settlement with Cigna to eliminate polices previously banning coverage for claims related to psychiatric testing following an ...

An emerging category of laboratory tests may help improve care and treatment outcomes for cancer patients, according to a recent survey by the nonprofit CancerCare, but insurers and employers do not ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s both cost-effective and life-saving. Delays in molecular testing for ...

LYNCHBURG, VA – Twelve years ago, Leecy Fink found herself in a doctor’s office, hearing the unthinkable—she had stage four breast cancer. The doctors caught it late. And in no time at all, it had ...

When the U.S. COVID-19 public health emergency ends this month, coronavirus tests will still be available, but there will be changes to who pays for them. Questions remain about exactly what those ...